Matches in SemOpenAlex for { <https://semopenalex.org/work/W766102754> ?p ?o ?g. }
- W766102754 endingPage "315" @default.
- W766102754 startingPage "309" @default.
- W766102754 abstract "Previous research has demonstrated that the nucleus accumbens is a site where opioids and cannabinoids interact to alter feeding behavior. However, the influence of the endocannabinoid 2-arachidonylglycerol (2-AG) on the well-characterized model of intra-accumbens opioid driven high-fat feeding behavior has not been explored. The present experiments examined high-fat feeding associated behaviors produced by the interaction of 2-AG and the μ-opioid receptor agonist DAla(2),N,Me-Phe(4),Gly-ol(5)-enkaphalin (DAMGO) administered into the nucleus accumbens. Sprague-Dawley rats were implanted with bilateral cannulae aimed at the nucleus accumbens and were co-administered both a sub-threshold dose of 2-AG (0 or 0.25 μg/0.5 μl/side) and DAMGO (0, 0.025 μg or 0.25 μg/0.5 μl/side) in all dose combinations, and in a counterbalanced order. Animals were then immediately allowed a 2h-unrestricted access period to a palatable high-fat diet. Consumption, number and duration of food hopper entries, and locomotor activity were all monitored. DAMGO treatment led to an increase in multiple behaviors, including consumption, duration of food hopper entry, and locomotor activity. However, combined intra-accumbens administration of DAMGO and a subthreshold dose of 2-AG led to a significant increase in number of food hopper entries and locomotor activity, compared to DAMGO by itself. The results confirm that intra-accumbens administration of subthreshold dose of the endogenous cannabinoid 2-AG increases the DAMGO-induced approach and locomotor behaviors associated with high-fat feeding." @default.
- W766102754 created "2016-06-24" @default.
- W766102754 creator A5004536455 @default.
- W766102754 creator A5033705759 @default.
- W766102754 creator A5071284741 @default.
- W766102754 creator A5075594617 @default.
- W766102754 creator A5083058086 @default.
- W766102754 creator A5087511851 @default.
- W766102754 date "2015-08-01" @default.
- W766102754 modified "2023-09-23" @default.
- W766102754 title "Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat" @default.
- W766102754 cites W1565534551 @default.
- W766102754 cites W1606443939 @default.
- W766102754 cites W1677404691 @default.
- W766102754 cites W1699530412 @default.
- W766102754 cites W1825807651 @default.
- W766102754 cites W1836729582 @default.
- W766102754 cites W1927429241 @default.
- W766102754 cites W1963482720 @default.
- W766102754 cites W1965562098 @default.
- W766102754 cites W1965679449 @default.
- W766102754 cites W1966010782 @default.
- W766102754 cites W1973484096 @default.
- W766102754 cites W1974934764 @default.
- W766102754 cites W1975957035 @default.
- W766102754 cites W1980209989 @default.
- W766102754 cites W1988089886 @default.
- W766102754 cites W1989073099 @default.
- W766102754 cites W1996309751 @default.
- W766102754 cites W1998562560 @default.
- W766102754 cites W2007064781 @default.
- W766102754 cites W2008171418 @default.
- W766102754 cites W2009835964 @default.
- W766102754 cites W2015591615 @default.
- W766102754 cites W2015614945 @default.
- W766102754 cites W2018527534 @default.
- W766102754 cites W2018769395 @default.
- W766102754 cites W2023235628 @default.
- W766102754 cites W2024653583 @default.
- W766102754 cites W2037412847 @default.
- W766102754 cites W2037811574 @default.
- W766102754 cites W2037843549 @default.
- W766102754 cites W2038682321 @default.
- W766102754 cites W2040106495 @default.
- W766102754 cites W2040749203 @default.
- W766102754 cites W2045065112 @default.
- W766102754 cites W2045608641 @default.
- W766102754 cites W2049900264 @default.
- W766102754 cites W2050252451 @default.
- W766102754 cites W2052972724 @default.
- W766102754 cites W2053232832 @default.
- W766102754 cites W2053399700 @default.
- W766102754 cites W2053400076 @default.
- W766102754 cites W2054170086 @default.
- W766102754 cites W2056188558 @default.
- W766102754 cites W2058996486 @default.
- W766102754 cites W2060123538 @default.
- W766102754 cites W2062084429 @default.
- W766102754 cites W2063924968 @default.
- W766102754 cites W2064128689 @default.
- W766102754 cites W2067408354 @default.
- W766102754 cites W2072201188 @default.
- W766102754 cites W2075894678 @default.
- W766102754 cites W2085741941 @default.
- W766102754 cites W2086784185 @default.
- W766102754 cites W2089714176 @default.
- W766102754 cites W2094354041 @default.
- W766102754 cites W2094801187 @default.
- W766102754 cites W2096012985 @default.
- W766102754 cites W2096529235 @default.
- W766102754 cites W2097215311 @default.
- W766102754 cites W2098766452 @default.
- W766102754 cites W2100224878 @default.
- W766102754 cites W2107832644 @default.
- W766102754 cites W2109659841 @default.
- W766102754 cites W2112692115 @default.
- W766102754 cites W2117726420 @default.
- W766102754 cites W2122680702 @default.
- W766102754 cites W2135962544 @default.
- W766102754 cites W2148813993 @default.
- W766102754 cites W2162532272 @default.
- W766102754 cites W2171065970 @default.
- W766102754 cites W2345682597 @default.
- W766102754 cites W4296759786 @default.
- W766102754 doi "https://doi.org/10.1016/j.brainres.2015.06.010" @default.
- W766102754 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4522234" @default.
- W766102754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26100333" @default.
- W766102754 hasPublicationYear "2015" @default.
- W766102754 type Work @default.
- W766102754 sameAs 766102754 @default.
- W766102754 citedByCount "7" @default.
- W766102754 countsByYear W7661027542015 @default.
- W766102754 countsByYear W7661027542016 @default.
- W766102754 countsByYear W7661027542017 @default.
- W766102754 countsByYear W7661027542022 @default.
- W766102754 countsByYear W7661027542023 @default.
- W766102754 crossrefType "journal-article" @default.
- W766102754 hasAuthorship W766102754A5004536455 @default.